A multicentric evaluation of recombinant DNA hepatitis B vaccine of Cuban origin.

INTRODUCTION: Hepatitis B infection is an important public health problem all over the world. As no specific treatment is available, greatest emphasis is placed on prevention through immunization. OBJECTIVE: To evaluate the immunogenicity (sero-protection rate) and reactogenicity of a novel recombinant DNA hepatitis B vaccine of Cuban origin (Enivac HB). POPULATION AND METHODS: The study was conducted at two independent centres (New Delhi and Jaipur) and 111 healthy volunteers without any symptomatic or serological evidence of HBV infection were administered the vaccine intramuscularly in a dose of 20 ug at day 0, day 30 and day 180. Blood samples were collected for evaluation of sero-protection on days 30, 60, 90 and 210 at both centres and, in addition, at day 120 at New Delhi. All subjects were evaluated for any adverse event for 120 hours subsequent to each dose of the vaccine. RESULTS: The mean age of the volunteers was 24 years and the male:female ratio was 61:50. An overall sero-protection rate of 24.3% was obtained at day 30, 68.5% at day 60, 94.5% at day 90 and 99.1% by day 120. Following the third dose of the vaccine (at day 180), we lost one subject to follow up and further evaluation could be done in a total of 110 volunteers. The sero-protection rate by day 210 was found to be 100% (110/110). The vaccine was well tolerated with no serious adverse reactions. Minor side effects such as injection site tenderness, erythema and/or low grade fever were observed in 4.5% of the subjects. CONCLUSIONS: The recombinant DNA hepatitis B vaccine of Cuban origin is safe, well tolerated and highly immunogenic.

Bacteriology of spirometer tubing and evaluation of methodology to prevent transmission of infection.

Transmission of respiratory infection by a spirometer is a definite risk in countries like India where a majority of respiratory diseases are infective in nature. To assess this problem, scrapings and washing from a spirometer tube in regular use were taken for microbiological studies. Significant bacterial growth on culture included Aspergillus and acid fast bacilli. In order to check contamination, a segregation chamber was attached to the spirometer. Twenty-three patients used the spirometer with or without segregation chamber and a good correlation was shown between the two methods in forced expiratory volume in one second (r = 0.94), forced vital capacity (r = 0.92) and mid maximum expiratory flow rate (r = 0.90). It can be concluded that a spirometer may have significant growth of pathogenic bacteria and a segregation chamber may be used routinely with the spirometer in order to prevent its contamination.

Vasculitis--a complication of hypothyroidism.

A case of hypothyroidism presenting with cutaneous vasculitis is described. Apart from typical findings of hypothyroidism, the patient had hypertension (HT). With thyroxine replacement therapy patient showed an improvement in hypothyroidism, HT and cutaneous vasculitis.

Comparative study of capillary and arterial, blood gas values in plastic and glass syringes at various intervals in normal and asthmatic subjects.

Fifty-six normal healthy subjects and forty-four patients with bronchial asthma were subjected to capillary and arterial blood gas analysis. Arterial blood values were measured immediately and at two and four hours interval after storing the samples between 0-4 degrees C using glass and plastic syringes. It was observed that PO2 of arterial blood was significantly higher (P less than 0.001) than capillary PO2 values, while material of syringe and time interval of analysis did not make any significant alteration. PCO2 and pH values in arterial samples at various intervals and in different syringes were comparable in normal as well as in asthmatic subjects.